University Hospital, Tours
361
54
61
216
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.6%
24 terminated/withdrawn out of 361 trials
90.0%
+3.5% vs industry average
15%
54 trials in Phase 3/4
1%
2 of 216 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (361)
Oxytocin vs Prostaglandins for Labor Induction of Women With an Unfavorable Cervix After 24h of Cervical Ripening
Role: lead
Method for bAdge-dosi Monitoring of X-ray Exposure Values in Operating Theatre Surgery
Role: lead
Evaluation of the Efficacy of Dissociation-Focused Cognitive Behavior Therapy
Role: lead
Comparison of Early Pleural Irrigation Strategy With Saline to the Standard of Care for the Management of Complicated Pleural Infections.
Role: collaborator
Inhaled Amikacin Versus Placebo in Patients With Ventilator-associated Tracheobronchitis
Role: lead
Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections
Role: collaborator
Acetylsalicylic Acid Versus Placebo as an add-on Treatment to Local Non-steroidal Anti-inflammatory Drug for the Management of Thrombotic Episodes in Superficial Venous Malformations in Children Aged 6 to 17 Years.
Role: lead
Role of BARriers in IgG-Pathogen Interactions at the Mucosal Surface in Human Airways
Role: lead
Channels of Communication & Brain Functioning: Pilot fMRI Study
Role: lead
Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients
Role: lead
Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies
Role: lead
Cerebral Abnormalities Detected by MRI, Realized at the Age of Term and the Emergence of Executive Functions
Role: lead
Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial-
Role: lead
Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea
Role: lead
Ultrasound for Acute Field Triage of Stroke
Role: lead
Collection of Primary Human
Role: lead
Cost-utility Analysis, Cost-effectiveness Analysis, Budget Impact Analysis
Role: lead
Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment
Role: lead
Individual Neurophysiological Sensory Profiles in People With and Without Neurodevelopmental Disorders
Role: lead
Features Emotional Responses in Adults With Autism: Comparison With Bipolar Disorder (REMBAU)
Role: lead